John G. Curd - Concepedia

Author

John G. Curd

Scripps Health ORCID

Also Known As

J Curd, J G Curd, J. Curd, J. G. Curd, J.G. Curd, JOHN G. CURD, John Curd, John G Curd, John G. Curd, Julia B. Curd

121

Publications

Citations

H-Index

151

Concepts

All Affiliations

Scripps Health Scripps Clinic University of California San Diego

About

John G. Curd is an author at Scripps Health specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	49	3.4K
2	Allergy	14	16	1.2K
3	Health Sciences	10	10	498
4	Natural Sciences	3	3	92
5	Allergy Medicine	2	2	77

John G. Curd

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Sjögren's syndrome. Proposed criteria for classification Robert I. Fox, Charles A. Robinson, John G. Curd, Arthritis & Rheumatism Elderly PatientsDiagnosisPathologyBiopsy SpecimensDermatology	1986	683
Effects of Protamine Administration after Cardiopulmonary Bypass on Complement, Blood Elements, and the Hemodynamic State James K. Kirklin, Dennis E. Chenoweth, David C. Naftel, The Annals of Thoracic Surgery Heart FailureCardiac AnaesthesiaHemodynamic StateBlood ElementsAnesthesia Practice	1986	245
Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary Angioedema M Schapira, Lee Silver, Cheryl F. Scott, New England Journal of Medicine Vascular DiseaseVasculitisImmunologyPathologyPharmacotherapy	1983	198
Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer Jessica D. Sun, Qian Liu, Jingli Wang, Clinical Cancer Research	2011	194
Prevalence of Congenital or Acquired Complement Deficiency in Patients with Sporadic Meningococcal Disease Richard T. Ellison, Peter F. Köhler, John G. Curd, New England Journal of Medicine Complement SystemAutoimmune DiseaseBacterial MeningitisVasculitisLupus	1983	173
Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. John G. Curd, Larry J. Prograis, Charles G. Cochrane The Journal of Experimental Medicine InflammationThrombosisPlasma PrekallikreinAutoimmune DiseaseAllergy	1980	134
The Isolation of Digoxin-Specific Antibody and Its Use in Reversing the Effects of Digoxin John G. Curd, Thomas W. Smith, Jean‐Claude Jaton, Proceedings of the National Academy of Sciences	1971	134
Calcaneal Abnormalities in Articular Disorders Donald Resnick, Mitchell L. Feingold, John G. Curd, Radiology AnatomyDermatologyOrthopaedic SurgeryPathologic LesionAchilles Tendon Ruptures	1977	129
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. C J Carrera, Chihiro Terai, Martin Lotz, Journal of Clinical Investigation ImmunotoxicologyImmunologyBlood CellCell DeathContinuous Cldado Infusion	1990	125
TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules Qian Liu, Jessica D. Sun, Jingli Wang, Cancer Chemotherapy and Pharmacology Translational MedicineHypoxia (Medicine)PharmacologyHypoxia-activated ProdrugClinical Pharmacology	2012	113

Page 1